Exercise Induced Asthma Clinical Trial
Official title:
Kinesio Tape Versus Myofascial Release of Respiratory Muscles on Athletes Performance With Exercise Induced Asthma
Verified date | September 2023 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Purpose of this study was to compare between the effects of kinesio tap and myofascial release of respiratory muscles on exercise induced asthma
Status | Completed |
Enrollment | 70 |
Est. completion date | May 20, 2023 |
Est. primary completion date | April 20, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 30 Years |
Eligibility | Inclusion Criteria: - Seventy male athlete with ages ranging from 18 to 28 years old. Their Body Mass Index ranged from "18.5" to "24.9". They have the same level of good aerobic fitness, muscular strength and endurance, and flexibility according to tests results; running or jogging test, push up or sit up test, and sit-and-reach test respectively. Exclusion Criteria: 1. Pulmonary disorders. 2. Metabolic disorders (e.g. Diabetes Mellitus). 3. Coronary artery disorders . 4. Neurological disorders. 5. Recent musculoskeletal injuries. 6. Renal disorders. 7. Hepatic disorders. 8. Skin hypersensitive. 9. Smokers |
Country | Name | City | State |
---|---|---|---|
Egypt | Khaled mohamed Ahmed zaki | Port Said | Port Said/el Manakh |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | pulse oximeter | Pao2:% | 2 months | |
Other | IFIS | General fitness | 2 months | |
Primary | Pulmonary function test | MVV :liter FVC:liter FEV1:liter FVC/FEV1:% VC:liter | 2 months | |
Secondary | Cooper's 12 minute run test | Vo2 max:ml/kg/min | 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05162703 -
Evaluation of Exercise Induced Bronchoconstriction Using a Novel Automated Digital Clinical Decision System
|
N/A | |
Completed |
NCT00989833 -
Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients
|
Phase 2 | |
Recruiting |
NCT03524053 -
Mediator Release During Exercise-induced Bronchoconstriction
|
N/A | |
Completed |
NCT03550456 -
Diagnostics and Quality of Life With EIA and EILO
|
||
Completed |
NCT00861185 -
Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma
|
Phase 2 | |
Recruiting |
NCT05105529 -
Adaptation to Ozone in Individuals With Asthma/Exercise-induced Bronchoconstriction
|
N/A | |
Terminated |
NCT01070888 -
Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma
|
Phase 4 | |
Recruiting |
NCT06336681 -
Inspiratory Muscle Training on The Severity of Exercise-Induced Bronchoconstriction and Time-Trial Performance (IMT_EIB)
|
Phase 2 | |
Completed |
NCT01942096 -
Study of Airway Inflammation in Relation to Exercise in Elite Athletes
|
||
Completed |
NCT00127166 -
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
|
Phase 3 | |
Recruiting |
NCT05174689 -
Epigenetic Regulation of Exercise Induced Asthma
|
N/A | |
Completed |
NCT01097954 -
A Prospective Study Measuring Exhaled Nitric Oxide in Exercise-Induced Asthma
|